These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 7091299)

  • 21. Specific inhibitor of complement (C5)-derived chemotactic activity in systemic lupus erythematosus related antigenically to the Bb fragment of human factor B.
    Perez HD; Hooper C; Volanakis J; Ueda A
    J Immunol; 1987 Jul; 139(2):484-9. PubMed ID: 3648093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antileukotactic properties of tumor cells.
    Brozna JP; Ward PA
    J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PMN chemotactic factor produced by glass-adherent cells in the acute inflammation caused by Paracoccidioides brasiliensis.
    Calich VL; Coppi Vaz CA; Burger E
    Br J Exp Pathol; 1985 Feb; 66(1):57-65. PubMed ID: 3882118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of systemic complement activation and neutrophil-mediated pulmonary injury on the retention and metastasis of circulating cancer cells in mouse lungs.
    Orr FW; Warner DJ
    Lab Invest; 1990 Mar; 62(3):331-8. PubMed ID: 2314052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotactic mechanisms and cancer metastasis.
    Orr FW; Varani J
    Pathol Annu; 1982; 17 Pt 2():307-30. PubMed ID: 7182755
    [No Abstract]   [Full Text] [Related]  

  • 26. Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis.
    Perez HD; Horn JK; Ong R; Goldstein IM
    J Lab Clin Med; 1983 Jan; 101(1):123-9. PubMed ID: 6848611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porcine spermadhesin PSP-I/PSP-II stimulates macrophages to release a neutrophil chemotactic substance: modulation by mast cells.
    Assreuy AM; Alencar NM; Cavada BS; Rocha-Filho DR; Feitosa RF; Cunha FQ; Calvete JJ; Ribeiro RA
    Biol Reprod; 2003 May; 68(5):1836-41. PubMed ID: 12606406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
    Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
    J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo dependency of chemokine generation on C5a and TNF-alpha.
    Czermak BJ; Sarma V; Bless NM; Schmal H; Friedl HP; Ward PA
    J Immunol; 1999 Feb; 162(4):2321-5. PubMed ID: 9973510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs.
    Rollins SA; Matis LA; Springhorn JP; Setter E; Wolff DW
    Transplantation; 1995 Dec; 60(11):1284-92. PubMed ID: 8525523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of guinea pig lymphocyte-derived chemotactic factor for fibroblasts.
    Postlethwaite AE; Kang AH
    J Immunol; 1980 Mar; 124(3):1462-6. PubMed ID: 7358987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zymosan, but not lipopolysaccharide, triggers severe and progressive peritoneal injury accompanied by complement activation in a rat peritonitis model.
    Mizuno M; Ito Y; Hepburn N; Mizuno T; Noda Y; Yuzawa Y; Harris CL; Morgan BP; Matsuo S
    J Immunol; 2009 Jul; 183(2):1403-12. PubMed ID: 19553534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonspecific activation of complement factor 5 by isolated Dermacentor andersoni salivary antigens.
    Gordon JR; Allen JR
    J Parasitol; 1991 Apr; 77(2):296-301. PubMed ID: 2010863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time course of chemotactic factor generation and the corresponding macrophage response to asbestos inhalation.
    Warheit DB; Hill LH; George G; Brody AR
    Am Rev Respir Dis; 1986 Jul; 134(1):128-33. PubMed ID: 3729150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of chemotactic factor, interleukin-8, from hepatocytes exposed to ethanol.
    Shiratori Y; Takada H; Hikiba Y; Nakata R; Okano K; Komatsu Y; Niwa Y; Matsumura M; Shiina S; Omata M
    Hepatology; 1993 Dec; 18(6):1477-82. PubMed ID: 8244273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The chemical mediation of delayed hypersensitivity skin reactions: III. Purification and characterization of a precursor protein for macrophage-chemotactic factor in normal guinea pig plasma.
    Ueda K; Kawaguchi T; Okamoto T; Kambara T
    Am J Pathol; 1982 Sep; 108(3):291-8. PubMed ID: 7114165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A paracrine migration-stimulating factor for metastatic tumor cells secreted by mouse hepatic sinusoidal endothelial cells: identification as complement component C3b.
    Hamada J; Cavanaugh PG; Miki K; Nicolson GL
    Cancer Res; 1993 Sep; 53(18):4418-23. PubMed ID: 8364938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of C5a antagonist by synovial and peritoneal tissue fibroblasts.
    Matzner Y; Gavison R; Shlomai Z; Ben-Bassat H; Liebergal M; Robinson DR; Babior BM
    J Cell Physiol; 1986 Nov; 129(2):215-20. PubMed ID: 3771654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioassay of blood-born tumour cells on in vivo and in vitro systems.
    Döbrössy L; Túri G
    Acta Morphol Acad Sci Hung; 1976; 24(4):331-40. PubMed ID: 1032278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.